Table 1.
Clinical Features of Subjects
| Parameters | Healthy Individuals (n = 101) | NAFLD Group (n = 116) | P value |
|---|---|---|---|
| Gender (Female/ Male) | 52/49 | 60/56 | 0.972 |
| Age (years) | 48.54 ± 9.69 | 49.80 ± 9.74 | 0.343 |
| BMI (kg/m2) | 21.92 ± 3.00 | 27.84 ± 2.98 | < 0.001 |
| HOMA-IR | 1.22 ± 0.09 | 3.62 ± 2.51 | < 0.001 |
| ALT (IU/l) | 22.16 ± 2.09 | 39.58 ± 6.19 | < 0.001 |
| FBG (mg/dl) | 90.63 ± 13.18 | 108.70 ± 35.40 | < 0.001 |
| TC (mg/dl) | 178.94 ± 23.53 | 196.11 ± 46.84 | 0.001 |
| TG (mg/dl) | 106.62 ± 15.33 | 130.61 ± 38.00 | < 0.001 |
Abbreviations: NAFLD, nonalcoholic fatty liver disease; BMI, body mass index; HOMA-IR, homeostasis model assessment insulin resistance; ALT, alanine transaminase; FBG, fasting blood glucose; TC, total cholesterol; TG, triglycerides.